Asthma disease control (CARAT, pharmacy dispensing data), medication adherence (MARS, pharmacy dispensing data), inhalation technique (checklist)
Conditions
Interventions
All participating pharmacists receive material and written instructions for patient selection, interventions and process registrations.
Patients from both groups are asked to fill in the CARAT and M
Sponsors
Radboud university medical centre, Radboud Institute for Health Sciences, IQ Healthcare, Nijmegen, The Netherlands
Eligibility
Inclusion criteria
Inclusion criteria: Patients are eligible when meeting following inclusion criteria: 1. Aged 18 years or older 2. Current user of asthma maintenance medication (ICS or combinations of ICS/LABA, at least one prescription in the previous six months) 3. Registered in the pharmacy 4. Willingness to visit the pharmacy and availability for duration of study 5. Current diagnosis of asthma 6. Speak, read and write the Dutch language sufficiently to complete the questionnaires
Exclusion criteria
Exclusion criteria: Patients with (con)current COPD, patients with low literacy and patients who receive palliative care will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome is the patient reported disease control, measured by the CARAT questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes are the disease control measured by pharmacy dispensing data for the number of exacerbations and use of rescue medication. Effectiveness of maintenance therapy is measured by inhalation technique (checklist at intervention session) and adherence (MARS). | — |
Contacts
Public ContactEsther Kuipers
Scientific Institute for Quality of Healthcare (IQ healthcare)- Geert Grooteplein 21 (route 114)
Outcome results
None listed